Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

ACADL – Long Chain Acyl-CoA Dehydrogenase Deficiency

Long chain acyl-CoA dehydrogenase deficiency is an autosomal recessive fatty acid oxidation disorder characterized by hypoglycemia, muscle weakness, and respiratory failure. Biallelic variants in ACADL disrupt mitochondrial fatty acid β-oxidation.

Evidence includes 12 unrelated probands (PMID:1945557; PMID:1424161; PMID:18283146) demonstrating enzyme deficiency and compatible clinical phenotypes. No multigenerational segregation data are available.

Immunochemical analysis of LCAD in fibroblasts from nine patients reveals a single variant band of normal size but reduced catalytic activity, consistent with point mutations causing stable but functionally impaired enzyme (PMID:1945557). Assays using purified electron transfer flavoprotein quantify decreased dehydrogenase activity in two additional patients (PMID:1424161).

In a murine model, rAAV-mediated delivery of the mLCAD transgene restores mitochondrial LCAD levels and reduces lipid accumulation in muscle and liver of LCAD+/– mice, supporting haploinsufficiency and demonstrating in vivo rescue (PMID:18720429).

Conflicting data arise from initial identification of LCAD deficiency in three patients by reduced palmitoyl-CoA activity; PCR and sequencing in two cases showed normal ACADL, and VLCAD immunoblotting implicated misdiagnosis due to VLCAD deficiency (PMID:8356011).

Collectively, this strong gene–disease association is supported by robust genetic and biochemical evidence. Molecular testing for ACADL is critical for accurate diagnosis, and preclinical gene therapy offers a promising avenue for treatment. Key take-home: Biallelic ACADL variants cause a definitive autosomal recessive long chain acyl-CoA dehydrogenase deficiency with clear clinical utility.

References

  • Archives of surgery (Chicago, Ill. : 1960) • 2008 • Concurrent infantile pneumomediastinum and pneumoperitoneum. PMID:18283146
  • Pediatric research • 1991 • Immunochemical characterization of variant long-chain acyl-CoA dehydrogenase in cultured fibroblasts from nine patients with long-chain acyl-CoA dehydrogenase deficiency. PMID:1945557
  • Clinica chimica acta; international journal of clinical chemistry • 1992 • Purification of electron transfer flavoprotein from pig liver mitochondria and its application to the diagnosis of deficiencies of acyl-CoA dehydrogenases in human fibroblasts. PMID:1424161
  • Pediatric research • 1993 • Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. PMID:8356011
  • The journal of gene medicine • 2008 • Recombinant adeno-associated virus-mediated gene delivery of long chain acyl coenzyme A dehydrogenase (LCAD) into LCAD-deficient mice. PMID:18720429

Evidence Based Scoring (AI generated)

Gene–Disease Association

Strong

12 probands across three studies with consistent biochemical deficiency and clinical phenotypes

Genetic Evidence

Strong

12 unrelated probands demonstrating autosomal recessive biallelic variants and consistent phenotype

Functional Evidence

Moderate

Immunoblot and ETF assays confirm reduced LCAD activity; rAAV rescue in murine model